Reducing Skin Cancer Risk in Childhood Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

726

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 1, 2018

Study Completion Date

January 1, 2018

Conditions
Skin Neoplasms
Interventions
BEHAVIORAL

Patient activation and education (PAE)

Text messaging and web-based tutorials for a 12-month duration (a website and smartphone interface)

BEHAVIORAL

PAE plus physician activation (PAE + MD)

Text messaging and web-based tutorials for a 12-month duration (a website and smartphone interface), physician activation/educational materials about: (1) survivors' increased skin cancer risk; (2) the benefits of and the skills needed to conduct full-body skin exams; and (3) the importance of recommending routine SSE to patients

BEHAVIORAL

PAE physician activation, plus teledermoscopy (PAE +MD +TD)

Text messaging and web-based tutorials for a 12-month duration (a website and smartphone interface), physician activation/educational materials about: (1) survivors' increased skin cancer risk; (2) the benefits of and the skills needed to conduct full-body skin exams; and (3) the importance of recommending routine SSE to patients, and participant receipt of a dermoscopic lens

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

St. Jude Children's Research Hospital

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

Emory University

OTHER

lead

Harvard School of Public Health (HSPH)

OTHER

NCT02046811 - Reducing Skin Cancer Risk in Childhood Cancer Survivors | Biotech Hunter | Biotech Hunter